PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1629632
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1629632
Drug Addiction Treatment Market, By Types, By Treatment, By Route of Administration, By End User,By Geography
The global drug addiction treatment market is estimated to be valued at USD 17.61 Bn in 2024 and is expected to reach USD 28.72 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 17.61 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 7.20% | 2031 Value Projection: | US$ 28.72 Bn |
The global drug addiction treatment market has been witnessing steady growth in the recent past owing to the rising prevalence of drug abuse across both developed and developing nations worldwide. In June 2020, according to the United Nations Office on Drugs and Crime (UNODC), around 269 million people worldwide used drugs at least once in 2020. The easy availability of illicit substances coupled with socio-economic vulnerabilities has significantly contributed to the drug addiction crisis. In response, governments across countries have been ramping up efforts to provide evidence-based treatment services to help individuals overcome substance use disorders. This has majorly driven the demand for various pharmacological and psychological addiction treatment drugs and therapies in the global drug addiction treatment market.
Market Dynamics:
The key drivers propelling the global drug addiction treatment market growth include growing social acceptance of drug abuse disorders as a medical condition requiring treatment instead of criminalization, increasing healthcare spending by governments to expand treatment facilities, and rising number of opioid analgesic users contributing to the opioid crisis. However, factors such as lack of social support programs post-detoxification, stigma associated with substance abuse treatment, and scarcity of medical professionals with specialized addiction treatment training pose challenges to market players. On the positive side, ongoing research for novel treatment drugs with better safety and efficacy profiles as well as integration of digital technologies in counseling programs present high-growth opportunities for stakeholders.
Key Features of the Study:
This report provides an in-depth analysis of the global drug addiction treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global drug addiction treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Indivior PLC, Pfizer Inc., Johnson & Johnson, Alkermes, Mallinckrodt Pharmaceuticals, Teva Pharmaceutical Industries, GSK Plc., AbbVie Inc., Otsuka Pharmaceutical Co., Ltd., Lundbeck A/S, Hikma Pharmaceuticals, Alkermes Plc., Sandoz (a Novartis division), AcelRx Pharmaceuticals, and Nuvectra Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global drug addiction treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug addiction treatment market
Market Segmentation
- By Types Insights (Revenue, USD Bn, 2019 - 2031)
- Opioid Addiction
- Benzodiazepine Addiction
- Barbiturate Addiction
- Others
- By Treatment Insights (Revenue, USD Bn, 2019 - 2031)
- Therapy
- Medication
- Others
- By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Parenteral
- Others
- By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Specialty Clinics
- Rehabilitation Center
- Others
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Indivior PLC
- Pfizer Inc.
- Johnson & Johnson
- Alkermes
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceutical Industries
- GSK Plc.
- AbbVie Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Lundbeck A/S
- Hikma Pharmaceuticals
- Alkermes Plc.
- Sandoz (a Novartis division)
- AcelRx Pharmaceuticals
- Nuvectra Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Drug Addiction Treatment Market, By Types
- Global Drug Addiction Treatment Market, By Treatment
- Global Drug Addiction Treatment Market, By Route of Administration
- Global Drug Addiction Treatment Market, By End User
- Global Drug Addiction Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Drug Addiction Treatment Market, By Types, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Opioid Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Benzodiazepine Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Barbiturate Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Drug Addiction Treatment Market, By Treatment, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Drug Addiction Treatment Market, By Route of Administration, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Drug Addiction Treatment Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Rehabilitation Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Drug Addiction Treatment Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Indivior PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alkermes
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceutical Industries
- GSK Plc.
- AbbVie Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Lundbeck A/S
- Hikma Pharmaceuticals
- Alkermes Plc.
- Sandoz (a Novartis division)
- AcelRx Pharmaceuticals
- Nuvectra Corporation
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
